InvestorsHub Logo
Followers 18
Posts 1387
Boards Moderated 0
Alias Born 10/21/2015

Re: Money $hot post# 13432

Monday, 02/01/2021 6:35:29 PM

Monday, February 01, 2021 6:35:29 PM

Post# of 16706
Here is why Algernon deserves BIG CREDIT:

I agree, it's the data readout is the most important of all, however, a few things remains true in pharma land:

1) It is an incredible amount to set up a clinical trial for a drug as it takes ethics approvals, government approvals, meeting safety milestones in the trial, and requires a significant coordinated initiative across many institutions and with many individuals/doctors/research associates involved. The protocol writing, each hospital passing ethics and enrolling patients and collecting data. ITS IMMENSE WORK.

Many people who invest have no idea the amount of work that goes on behind the scenes, they just go online and demand results. Small companies that pull off big trials have EARNED RESPECT NO MATTER THE RESULT OF THE TRIAL.

FACT: These guys have earned MASSIVE respect for pulling off one of the most incredible COVID trials to date.

2) Finding signal is like hitting the jackpot. It's completely out of the companies control. It has nothing to do with Algernon. They picked a drug that scientifically and mechnistically SHOULD WORK. Whether it ACTUALLY works is out of their control.

FACT: They don't control the signal. They just pick the drug that SHOULD work and hope for the best. And that they have done. Wonderfully.

3) They can't guarantee a trial will be successful... like I said, it's out of their control... so they MUST prepare to be one step ahead moving forward so investors and the company aren't left in a dead period between releasing COVID results and the next drug they investigate.

FACT: They deserve credit for thinking ahead and being one step ahead of the game. THEY ARE RELENTLESS. MARK IS A BEAST...

AMG, stay strong and let's stay positive

Invest in the science.